Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Philip Morris International
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Philip Morris International reported a strong 2024 third-quarter performance, with a 49.2% increase in reported diluted EPS to $1.97 and a 14.4% increase in adjusted diluted EPS to $1.91. The company raised its 2024 full-year guidance for reported diluted EPS to $6.20-$6.26 and adjusted diluted EPS to $6.45-$6.51, driven by robust smoke-free product sales and resilient combustible performance[1][2][3].
Philip Morris International marked a decade of IQOS, a milestone in its journey to a smoke-free future, highlighting the product's significant impact on reducing harmful smoke exposure since its launch[3][4].
Philip Morris International's subsidiary, Vectura Fertin Pharma, announced the sale of Vectura Group to Molex Asia Holdings for GBP 150 million upfront, with potential deferred payments of up to GBP 148 million, as part of its strategy to focus on oral consumer health and inhaled prescription products[2][3].
Open job positions at Philip Morris International
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
PRAKTIKUM IM BEREICH MARKETING (M/W/D)
Remote Sales Assistant
Financial Reporting & Analytics (Surabaya)